How Much Did Linear Health Sciences Raise?
Funding & Key Investors

Linear Health Sciences has successfully secured a significant capital injection, bringing its total funding to $1.5M. This latest major strategic investment of $1.5M underscores the market confidence in the company's specialized approach to medical device safety. By addressing critical vulnerabilities in clinical environments, the firm is positioning itself as a pivotal player in the medical technology landscape, leveraging this recent financing to accelerate its operational trajectory and product deployment.

What is Linear Health Sciences?

Linear Health Sciences
ManufacturingMedical Devices & Equipment

Linear Health Sciences operates at the intersection of patient safety and medical engineering, focusing on the development of proprietary solutions designed to mitigate the risks associated with IV dislodgements. The company's flagship innovation, the Orchid SRV, utilizes advanced breakaway safety-valve technology to provide a seamless integration into existing clinical workflows. By prioritizing pediatric patient care, where the risk of accidental tubing removal is disproportionately high, Linear Health Sciences addresses a significant unmet need in hospital settings. Their commitment to enhancing the healthcare experience for both caregivers and patients has earned them recognition within the competitive Medtech Innovator ecosystem, establishing the company as a high-potential entity in the medical device sector.

How much funding has Linear Health Sciences raised?

Linear Health Sciences has raised a total of $1.5M across 1 funding round:

2017

Unspecified

$1.5M

Unspecified (2017): $1.5M with participation from i2E, Inc.

Key Investors in Linear Health Sciences

i2E, Inc.

A specialized engineering firm providing technical assistance and project monitoring, with a focus on industrial risk management and environmental solutions.

What's next for Linear Health Sciences?

With this recent infusion of capital, Linear Health Sciences is well-positioned to scale its manufacturing capabilities and expand its market reach. The strategic focus will likely shift toward broader clinical adoption of the Orchid SRV, ensuring that healthcare facilities can effectively reduce the costs and complications associated with IV dislodgement. As the company moves beyond its initial development phase, the focus will remain on rigorous clinical validation and the potential expansion of its product portfolio to address other critical areas of medical tubing safety. This growth phase is expected to solidify the company's reputation as a leader in patient-centric medical technology, potentially attracting further institutional interest as they continue to demonstrate the efficacy and scalability of their proprietary safety solutions.

See full Linear Health Sciences company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingPlastic, Packaging & Containers
ManufacturingMedical Devices & EquipmentBusiness ServicesResearch & Development
ManufacturingMedical Devices & EquipmentBusiness ServicesResearch & Development
Building MaterialsManufacturingIndustrial Machinery & EquipmentAutomotive Service & Collision RepairConsumer Services

Frequently Asked Questions Regarding Linear Health Sciences Financial Insights

What are the most recent funding rounds that Linear Health Sciences has completed, and what were the funding rounds?
Linear Health Sciences has recently completed 1 funding rounds: Unspecified on Dec 11, 2017.
What is the total amount of funding Linear Health Sciences has raised to date?
Linear Health Sciences has raised a total of $1.5M in funding to date.
How many funding rounds has Linear Health Sciences completed?
Linear Health Sciences has completed 1 funding rounds.
How much funding did Linear Health Sciences raise in its most recent funding round?
Linear Health Sciences raised $1.5M in its most recent funding round.
Who are the lead investors in Linear Health Sciences's latest funding round?
The lead investor in Linear Health Sciences's latest funding round was i2E, Inc.. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Linear Health Sciences's history?
The largest funding round in Linear Health Sciences's history was $1.5M.
See more information about Linear Health Sciences